|
|
AlphaProfit Sector Investors' NewsletterFidelity Select Funds and ETFs Investment Newsletter |
| About Newsletter | Performance | Full Service | Free Report | Renew Subscription | Login | Contact Us |
AlphaProfit Newsletter
Trusted resource that enables investors and investment advisors to create market-beating portfolios.
Proven process selects winners from over 300 sector funds and ETFs from Fidelity, ProFunds, Rydex, iShares, PowerShares, and many more
Newsletter offers model portfolios for different investment objectives
Model portfolios seek market beating after-tax returns while managing risk
Top ranked by Hulbert Financial and highly acclaimed by MarketWatch
More on mutual fund & ETF recommendations and model portfolios
Full Service
Profit in multiple ways from
Winning Fidelity Select funds, sector funds, and sector ETFs
Market-beating model portfolios
Opportunistic short-term trades
High-potential stock recommendations
More about investment newsletter
| Subscribe |
Free Service
Privacy-protected service helps you learn more about the Newsletter
Receive current market outlook
Earn subscription discounts
Gain complimentary login access
| Free Report |
Model Portfolio Performance
No exaggerated claims! Subscribers have earned such returns in their investment accounts without margin or leverage while considering risk and tax implications.
Model Port. |
Inception |
Returns* as of 6/30/2008 |
|||||
|
June |
YTD |
1 year |
3 year |
4 year |
Inception |
||
|
AlphaProfit Focus |
09/30/2003 |
-2.1% |
-2.3% |
-6.2% |
11.5% |
13.4% |
18.0% |
|
AlphaProfit Core |
09/30/2003 |
-6.6% |
-7.5% |
-5.6% |
10.1% |
9.2% |
12.5% |
|
S&P 500 |
|
-8.4% |
-11.9% |
-13.1% |
4.4% |
4.9% |
7.4% |
* Returns longer than 1 year annualized
What's New?
July Indicator Update
June Repositioning Alert
June Report
What People Say![]()
It has become apparent to me that you have a logical process that works. And the price of the subscription is the cheapest money management fee I will ever pay.
Dan Belville, TX
About AlphaProfit
|
AlphaProfit Investments is an independent investment research firm based in the greater Houston area. |
|
Sam Subramanian PhD, MBA |
Sam Subramanian founded AlphaProfit in 2003 after honing his financial skills for over 20 years. AlphaProfit uses novel processes for portfolio construc- |
|
tion and management. |
|
Investment Approach
Subscribers earn superior returns with lower risk and little effort.
Our investment approach
Selects winning sectors based on valuation, momentum, and news quality
Reduces risk through portfolio approach
Maximizes after-tax return and Keeps expenses low
AlphaProfit News
(07/01) Beat the S&P 500 Consistently!
(06/19) Thrive in Tough Times!
(06/12) Profiting from Featured Stock!
(06/01) Model Portfolios Better Benchmark
(05/12) Featured Stock Rocks!
(05/01) Strong Start to Q2!
(04/21) Prudently Beat the Market!
(04/12) Model Portfolios Lead the Market!
AlphaProfit Articles
AlphaProfit in the Media
Performance and Report Highlights
Popular AlphaProfit Articles
Discover the secrets to successfully investing in mutual funds, sector funds, and exchange traded funds or ETFs.
AlphaProfit in the Media
Leading financial journalists often quote Sam's views on sectors in publications such as Forbes, Investor's Business Daily, and MarketWatch.
|
|
AlphaProfit Certified by Go Daddy's High- Assurance Program |
Address
AlphaProfit Investments, LLC
2803 Arrowhead Drive
Sugar Land, TX 77479
AlphaProfit Investments, LLC neither is associated with nor receives any compensation from Fidelity Investments.
Past performance is neither an indication of nor a guarantee for future results.
This page is best viewed in 1024 by 768 pixels screen resolution or higher.
Disclosure -
Subscriber Agreement -
Privacy Policy
Site Map -
Link Partnership -
AlphaProfit Directory
Copyright © 2003-2008 AlphaProfit Investments, LLC. All rights reserved.
Top Performers
July Winners
Fidelity Select Funds
Fidelity Select Biotechnology (FBIOX) 1.32%
Fidelity Select Pharmaceuticals (FPHAX) 0.70%
Sector ETFs & ETNs
iShares Silver Trust (SLV) 4.27%
iShares Nasdaq Biotech. (IBB) 3.30%
Fidelity Domestic Equity Funds
Fidelity Mega Cap Stock (FGRTX) -1.21%
Fidelity Equity-Income II (FEQTX) -1.30%